Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from abicipar pegol?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my vision be monitored closely during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration clinical trial (NCT02462928). Contact the study team or your healthcare provider for specific answers.

What this study is about